Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJae Hyung Park, Andrew Wang, Hélder A. Santos
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Hierarchical ROS-scavenging platform breaks vicious cycle of stem cell senescence, angiogenesis arrest, and immune dysregulation in diabetic wounds
10.1016/j.jconrel.2025.114247 · 2025
A smart ROS-responsive hydrogel for on-demand antibacterial and platelet-rich plasma (PRP) activation in diabetic wound healing
10.1016/j.jconrel.2025.114392 · 2025
Combined M1 macrophage inhibition and thermotherapy for controlled fibroplasia and accelerated wound repair via an oxygenating ROS-responsive hydrogel
10.1016/j.jconrel.2025.114554 · 2026
PtCu-bimetallic modified MOF nanozyme composites for alleviating acute liver injury via reactive oxygen species elimination and inflammation regulation
10.1016/j.jconrel.2026.114774 · 2026
Self-disintegrating electrospun short fibers as intra-articular drug depots for gouty arthritis
10.1016/j.jconrel.2026.114817 · 2026
Pomegranate-inspired bionic microgel/periosteum composite harnessing reactive oxygen species for immune-engineered bone regeneration
10.1016/j.jconrel.2026.114818 · 2026
ROS-amplifying nanoregulators: precision thioredoxin reductase-targeted disruption of redox homeostasis overcomes tumor redox resistance
10.1016/j.jconrel.2025.114580 · 2026
Bioorthogonal Cu-MOF nanocatalyst enables GSH-triggered in situ drug synthesis for xCT-driven ferroptosis in colorectal cancer
10.1016/j.jconrel.2026.114775 · 2026
Low-dose radiation generated ROS-activatable doxorubicin prodrug loaded liposome nanoparticles for triple-negative breast cancer treatment
10.1016/j.jconrel.2026.114750 · 2026
ROS-responsive self-immolative polymeric prodrug for nitrosative stress-mediated cancer therapy
10.1016/j.jconrel.2026.114642 · 2026
Self-assembled multicomponent prodrugs with GSH/ROS site-responsiveness enable spatiotemporally controlled release for treating resistant NSCLC
10.1016/j.jconrel.2026.114654 · 2026
Glucose-responsive cascade nanozyme for controlled ROS release and bacterial carbon metabolic reprogramming in infected diabetic wounds
10.1016/j.jconrel.2025.114590 · 2026
Nanotechnology-based strategies for ROS-mediated anticancer and antimicrobial therapies
10.1016/j.jconrel.2026.114922 · 2026
Inflammation-responsive DNA hydrogel integrating probiotic outer membrane vesicles for infection monitoring and precision therapy of diabetic wounds
10.1016/j.jconrel.2025.114594 · 2026
Enhanced intracellular delivery of multi-responsive and size-switchable nanoparticles via microneedles for targeted psoriasis therapy
10.1016/j.jconrel.2025.114448 · 2026
Redox-active microneedles for disease management
10.1016/j.jconrel.2026.114717 · 2026
ROS-responsive nanodiscs for STING-NF-κB pathway inhibition and glycosaminoglycan layer restoration in interstitial cystitis/bladder pain syndrome therapy
10.1016/j.jconrel.2026.114907 · 2026
ROS-responsive self-assembly of baicalin-peptide as a ‘Molecular Latch’ to break the endothelial-to-mesenchymal transition-inflammation loop in atherosclerotic plaques
10.1016/j.jconrel.2026.114821 · 2026
Nanomedicines in ischemic cardiovascular and cerebrovascular diseases: theranostic technologies based on reactive oxygen species
10.1016/j.jconrel.2026.115050 · 2026
Oxidative cues as theranostic switches for the ROS-responsive nanotheranostics in oxidative stress-driven diseases
10.1016/j.jconrel.2026.114933 · 2026
Recent advances in ROS-modulating materials for sepsis treatment
10.1016/j.jconrel.2026.114779 · 2026
The design of activatable photosensitizers and applications in precision immunomodulation
2026
Reactive oxygen species in lipid nanoparticle-based nucleic acid delivery: mechanisms and engineering
10.1016/j.jconrel.2026.114820 · 2026
No additional external references are available.